Darwinian Approaches for Cancer Treatment: Benefits of Mathematical Modeling

Sophia Belkhir1,2, Frederic Thomas1, Benjamin Roche1,3

  • 1CREEC/MIVEGEC, Université de Montpellier, CNRS, IRD, 34394 Montpellier, France.

Cancers
|September 10, 2021
PubMed

Insights

Adaptive therapy adjusts cancer treatments to tumor evolution, controlling resistant cells. Mathematical modeling aids in designing and assessing these evolution-based strategies for better treatment outcomes.

Area of Science:

  • Oncology
  • Evolutionary Biology
  • Mathematical Biology

Background:

  • Traditional cancer treatments often fail due to the emergence of drug-resistant cells.
  • Understanding tumor eco-evolutionary dynamics is key to overcoming treatment resistance.
  • Adaptive therapy offers a promising evolution-based strategy to manage resistant cell populations.

Purpose of the Study:

  • To review the benefits of in silico modeling for designing adaptive therapy strategies.
  • To assess the potential of adaptive therapy to improve cancer treatment outcomes.
  • To explore how mathematical models can inform experimental and clinical applications of adaptive therapy.

Main Methods:

  • Review of mathematical models, including Lotka-Volterra equations and agent-based models.
  • Analysis of how these models simulate tumor dynamics under adaptive therapy.
  • Discussion on integrating computational models with experimental and clinical research.

Main Results:

  • In silico modeling is beneficial for designing and evaluating adaptive therapy.
  • Mathematical models provide insights into controlling treatment-resistant cancer cell populations.
  • Specific model types, Lotka-Volterra and agent-based models, have been instrumental in advancing adaptive therapy research.

Conclusions:

  • Adaptive therapy, guided by mathematical modeling, shows potential for improved cancer treatment outcomes.
  • In silico approaches are crucial for predicting and optimizing adaptive therapy strategies.
  • Integration of modeling with experimental and clinical studies is essential for advancing adaptive therapy in practice.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
309
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
159